Hypothalamic ATF3 is involved in regulating glucose and energy metabolism in mice

Diabetologia

Volumn 56, Issue 6, 2013, Pages 1383-1393

  Lee, Y S ^a   Sasaki, T ^a   Kobayashi, M ^a   Kikuchi, O ^a   Kim, H J ^a   Yokota Hashimoto, H ^a   Shimpuku, M ^a   Susanti, V Y ^a   Ido Kitamura, Y ^a   Kimura, K ^b   Inoue, H ^b   Tanaka Okamoto, M ^c   Ishizaki, H ^c   Miyoshi, J ^c   Ohya, S ^d   Tanaka, Y ^d   Kitajima, S ^d   Kitamura, T ^a  

^a GUNMA UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^d Tokyo Medical and Dental University ^*  (Japan)

Author keywords

Agrp; ATF3; Energy expenditure; Food intake; FoxO1; Hypothalamus

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; AGOUTI RELATED PROTEIN; GLUCAGON; GLUCOSE; INSULIN; TRANSCRIPTION FACTOR FKHR;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LINE; CONTROLLED STUDY; ENERGY EXPENDITURE; ENERGY METABOLISM; FOOD INTAKE; GLUCAGON BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HYPOTHALAMUS; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LIPID DIET; METABOLIC DISORDER; METABOLIC REGULATION; MOUSE; NONHUMAN; OBESITY; PANCREAS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SYMPATHETIC TONE; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

ACTIVATING TRANSCRIPTION FACTOR 3; AGOUTI-RELATED PROTEIN; ALLELES; ANIMALS; CELL LINE; ENERGY METABOLISM; FORKHEAD TRANSCRIPTION FACTORS; GLUCOSE; HYPOTHALAMUS; INSULIN; INTEGRASES; ISLETS OF LANGERHANS; METABOLIC SYNDROME X; MICE; MICE, KNOCKOUT; PHENOTYPE; PROMOTER REGIONS, GENETIC; TIME FACTORS;

EID: 84877767230     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-2879-z     Document Type: Article

References (36)

1. Kahn R, Buse J, Ferrannini E, Stern M (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28:2289-2304
2. Alberti KG, Zimmet PZ (2008) Should we dump the metabolic syndrome? BMJ 336:641
3. Shoelson SE, Lee J, Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest 116:1793-1801
4. Barsh GS, Schwartz MW (2002) Genetic approaches to studying energy balance: perception and integration. Nat Rev Genet 3:589-600
5. Schwartz MW, Porte D Jr (2005) Diabetes, obesity, and the brain. Science 307:375-379
6. Kubota N, Terauchi Y, Tobe K et al (2004) Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus. J Clin Invest 114:917-927
7. Lin X, Taguchi A, Park S et al (2004) Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J Clin Invest 114:908-916
8. Accili D, Arden KC (2004) FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117:421-426
9. Kitamura T, Feng Y, Kitamura YI et al (2006) Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat Med 12:534-540
10. Kim HJ, Kobayashi M, Sasaki T et al (2012) Overexpression of FoxO1 in the hypothalamus and pancreas causes obesity and glucose intolerance. Endocrinology 153:659-671
11. Montminy M (1997) Transcriptional regulation by cyclic AMP. Annu Rev Biochem 66:807-822
12. Hai T, Hartman MG (2001) The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 273:1-11
13. Green TA, Alibhai IN, Unterberg S et al (2008) Induction of activating transcription factors (ATFs) ATF2, ATF3, and ATF4 in the nucleus accumbens and their regulation of emotional behavior. J Neurosci 28:2025-2032
14. Hai T, Wolford CC, Chang YS (2010) ATF3, a hub of the cellular adaptive-response network, in the pathogenesis of diseases: is modulation of inflammation a unifying component? Gene Expr 15:1-11
15. Nawa T, Nawa MT, Adachi MT et al (2002) Expression of transcriptional repressor ATF3/LRF1 in human atherosclerosis: colocalization and possible involvement in cell death of vascular endothelial cells. Atherosclerosis 161:281-291
16. Cai Y, Zhang C, Nawa T et al (2000) Homocysteine-responsive ATF3 gene expression in human vascular endothelial cells: activation of c-Jun NH(2)-terminal kinase and promoter response element. Blood 96:2140-2148
17. Wang J, Webb G, Cao Y, Steiner DF (2003) Contrasting patterns of expression of transcription factors in pancreatic alpha and beta cells. Proc Natl Acad Sci U S A 100:12660-12665
18. Hartman MG, Lu D, Kim ML et al (2004) Role for activating transcription factor 3 in stress-induced beta-cell apoptosis. Mol Cell Biol 24:5721-5732
19. Wang J, Cao Y, Steiner DF (2003) Regulation of proglucagon transcription by activated transcription factor (ATF) 3 and a novel isoform, ATF3b, through the cAMP-response element/ATF site of the proglucagon gene promoter. J Biol Chem 278:32899-32904
20. Zmuda EJ, Qi L, Zhu MX, Mirmira RG, Montminy MR, Hai T (2010) The roles of ATF3, an adaptive-response gene, in high-fat-diet-induced diabetes and pancreatic beta-cell dysfunction. Mol Endocrinol 24:1423-1433
21. Li D, Yin X, Zmuda EJ et al (2008) The repression of IRS2 gene by ATF3, a stress-inducible gene, contributes to pancreatic beta-cell apoptosis. Diabetes 57:635-644
22. Zhang SJ, Buchthal B, Lau D et al (2011) A signaling cascade of nuclear calcium-CREB-ATF3 activated by synaptic NMDA receptors defines a gene repression module that protects against extrasynaptic NMDA receptor-induced neuronal cell death and ischemic brain damage. J Neurosci 31:4978-4990
23. Guerra-Crespo M, Perez-Monter C, Janga SC et al (2011) Transcriptional profiling of fetal hypothalamic TRH neurons. BMC Genom 12:222
24. Kawauchi J, Zhang C, Nobori K et al (2002) Transcriptional repressor activating transcription factor 3 protects human umbilical vein endothelial cells from tumor necrosis factor-alpha-induced apoptosis through down-regulation of p53 transcription. J Biol Chem 277:39025-39034
25. Gu G, Dubauskaite J, Melton DA (2002) Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 129:2447-2457
26. Taketani K, Kawauchi J, Tanaka-Okamoto M et al (2012) Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells. Oncogene 31:2210-2221
27. Kitamura T, Kido Y, Nef S, Merenmies J, Parada LF, Accili D (2001) Preserved pancreatic beta-cell development and function in mice lacking the insulin receptor-related receptor. Mol Cell Biol 21:5624-5630
28. Wicksteed B, Brissova M, Yan W et al (2010) Conditional gene targeting in mouse pancreatic ss-Cells: analysis of ectopic Cre transgene expression in the brain. Diabetes 59:3090-3098
29. Seale P, Conroe HM, Estall J et al (2011) Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. J Clin Invest 121:96-105
30. Ohno H, Shinoda K, Spiegelman BM, Kajimura S (2012) PPARgamma agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. Cell Metab 15:395-404
31. Ebihara K, Ogawa Y, Katsuura G et al (1999) Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action. Diabetes 48:2028-2033
32. Fukuda M, Jones JE, Olson D et al (2008) Monitoring FoxO1 localization in chemically identified neurons. J Neurosci 28:13640-13648
33. Qian S, Chen H, Weingarth D et al (2002) Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell Biol 22:5027-5035
34. Wortley KE, Anderson KD, Yasenchak J et al (2005) Agouti-related protein-deficient mice display an age-related lean phenotype. Cell Metab 2:421-427
35. Bewick GA, Gardiner JV, Dhillo WS et al (2005) Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB J 19:1680-1682
36. Chen BP, Liang G, Whelan J, Hai T (1994) ATF3 and ATF3 delta Zip. Transcriptional repression versus activation by alternatively spliced isoforms. J Biol Chem 269:15819-15826